Medtronic Stock Rated Outperform as Renal Denervation and Spin-Off Drive Growth Potential
Medtronic, Inc. (NYSE:MDT) ranks among the top stocks for an early retirement portfolio. On June 18, RBC Capital reiterated a $101 price target and an Outperform rating on Medtronic, Inc.